Log in to your Inderes Free account to see all free content on this page.
Alzinova
0.92 SEK
+25.62 %
Less than 1K followers
ALZ
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Alzinova
EV/S
Median 2019-2020
P/B
Median 2019-2024
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Share price (SEK) | 7.52 | 5.58 | 4.67 | 2.24 | 2.46 | 3.46 |
| Shares | 13.7 | 21.8 | 22.4 | 40.0 | 55.0 | 89.2 |
| Market cap | 103.0 | 121.5 | 104.4 | 89.8 | 135.2 | 308.5 |
| Enterprise value | 69.3 | 65.5 | 75.6 | - | - | - |
| EV/S | 10.2 | 4.4 | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | - | - | - |
| EV/EBIT | neg. | neg. | neg. | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 1.74 | 1.27 | 1.18 | 0.85 | 1.19 | 2.49 |
| P/S | 15.1 | 8.2 | - | - | 500.6 | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 93.0 % | 95.2 % | 96.5 % | 94.5 % | 92.4 % | 92.9 % |
| Gearing ratio | - | - | - | - | - | - |
Login required
This content is only available for logged in users